Propisivačke medikacijske pogreške za hospitalizirane bolesnike: Prospektivna studija

Scientific paper - Original scientific paper

• Title (english): Prescribing medication errors in hospitalised patients: A prospective study
• Author: Vesna Bacic Vrca
• Author: Mira Becirevic-Lacan
• Author: Velimir Bozikov
• Author: Mladen Birus
• Author's institution: University of Zagreb; Faculty of Pharmacy and Biochemistry; (Centre for applied pharmacy)
• Author's institution: University of Zagreb; Faculty of Pharmacy and Biochemistry; (Department of pharmaceutical technology)
• Author's institution: University of Zagreb; Faculty of Pharmacy and Biochemistry; (Department of general and inorganic chemistry)
• Scientific / art field, discipline and subdiscipline: BIOMEDICINE AND HEALTHCARE; Pharmacy; Pharmacy

Abstract (croatian)

Svrha ove prospektivne studije je ispitivanje pojavnosti i vrsta medikacijskih pogrešaka u propisivanju i prevenciji njihovog nastanka. Podaci ispitivanja odnose se na 4951 propisani lijek, u razdoblju od 25 tjedana 2002. godine. Ispitivane medikacijske pogreške definirane su kao: pogrešna doza, pogrešan interval doziranja, dupliciranje terapije, te interakcija lijekova. Pojavnost medikacijskih pogrešaka propisivanja na ispitivanom uzorku, ukljucujuci sve teoretski moguce interakcije lijekova, iznosila je 14.7%. Medutim, kako je samo 8 interakcija (od ukupno 356 teoretski mogucih) ocijenjeno klinicki znacajnim, ukupan broj medikacijskih pogrešaka iznosio je 379 (od 4951 zapisa), što odgovara pojavnosti od 7.7%. Pogreška doziranja lijeka bila je najcešca vrsta uocenih medikacijskih pogrešaka. Utvrdena je velika razlika izmedu incidencije teoretski mogucih i klinicki znacajnih interakcija lijekova (7.2 vs. 0.2%). Nužan je kriticki pristup procjeni dostupnih podataka vezanih za interakcije lijekova. Rezultati našeg istraživanja upucuju na nužnost sustavnog nadzora propisane terapije, koji bi se mogao osigurati primjenom sustava raspodjele jedinicne terapije. U Hrvatskoj bi se trebao uspostaviti program pracenja medikacijskih pogrešaka, kako u bolnicama tako i na nacionalnoj razini.

Abstract (english)

The aims of this prospective study were to determine the incidence and types of prescribing medication errors and ways to prevent them from reaching patients. Data were collected from 4951 prescriptions over a 25 week period in 2002. Medication errors were classified as: incorrect dose, incorrect dose interval, duplication of therapy and drug interactions. The medical record analysis was used to compare prescribing with Croatian literature drug data and AHFS first Web version 2 (American Society of Health System Pharmacists). The incidence of medication errors in the entire sample, including all potential drug interactions, was 14.7%. However, as only 8 interactions (out of 356 potentially possible interactions) were assessed as clinically significant, then the total number of all types of medication errors equals 379. This resulted in an incidence of 7.7%. Dosage errors were the most frequent errors, followed by incorrect interval, drug duplication and drug interaction. The difference between the incidence of potentially possible and clinically significant drug interactions was quite large (7.2 vs. 0.2%). Thus, a critical attitude is necessary when evaluating data on drug interactions. Our findings point to the need of systematic control of prescribed therapies, which could be ensured by the application of the Unit Dose Drug Distribution System. A medication errors reporting program should be established both at hospital and at national levels in Croatia.

• Keywords (croatian): interakcije lijekova; medikacijske pogreške; propisivanje lijekova; prospektivna studija
• Keywords (english): drug interactions; hospitalised patients; medication errors; prescribing; prospective study
• Language: croatian
• Language: english
• Publication type: Scientific paper - Original scientific paper
• Publication status: Published
• Peer review: Peer review - international
• Publication version: Published version
• Journal title: Acta Pharmaceutica
• Numbering: vol. 55, no. 2, pp. 157-167
• p-ISSN: 1330-0075
• e-ISSN: 1846-9558
• URN:NBN: urn:nbn:hr:163:026535
• Publication: 2005
• Document URL: https://hrcak.srce.hr/16753
• Type of resource: Text
• Access conditions: Open access
• Created on: 2020-04-08 15:07:02